Axillary Surgery Following Neoadjuvant Chemotherapy - Multidisciplinary Guidance From the Association of Breast Surgery, Faculty of Clinical Oncology of the Royal College of Radiologists, UK Breast Cancer Group, National Coordinating Committee for Breast Pathology and British Society of Breast Radiology.
Goyal, Amit
Goyal, Amit
Abstract
AIMS: These multidisciplinary guidelines aim to provide clinically helpful, evidence-based recommendations on the surgical management of the axilla in patients who have received neo-adjuvant chemotherapy for early breast cancer. MATERIALS & METHODS: Following a review of published evidence, a writing group representing all disciplines quorate within a breast cancer multidisciplinary meeting prepared the guidelines. KEY RECOMMENDATIONS: In patients presenting with clinically node negative axillae, sentinel node biopsy (SNB) may be performed prior to or on completion of neo-adjuvant chemotherapy (NACT). In patients presenting with clinically node positive axillae, SNB may be safely considered following completion of NACT. Four nodes should be removed with dual mapping. If evidence of complete pathological response of previous metastases is seen, axillary radiotherapy may be offered. If residual cancer (isolated tumour cells, micro- or macrometastes) is seen within the SNB, offer axillary node dissection.
MIDER Authors
Affiliations
Citations
Altmetric:
Date
2019-06
Type
Article
Subject
Collections
Citation
Clin Oncol (R Coll Radiol). 2019 Jun 19. pii: S0936-6555(19)30247-X. doi: 10.1016/j.clon.2019.05.021. [Epub ahead of print]
Journal / Source Title
DOI
PMID
Publisher
Publisher’s URL
Publisher’s statement
Author(s) Pre or Post Print Version Only